782 related articles for article (PubMed ID: 31982990)
1.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
2. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of
Chen K; Wang J; Li S; Zhou W; Xu W
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1869-1880. PubMed ID: 36808002
[TBL] [Abstract][Full Text] [Related]
4. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
6. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
7. Role of
Akimoto E; Kadoya T; Kajitani K; Emi A; Shigematsu H; Ohara M; Masumoto N; Okada M
Clin Breast Cancer; 2018 Feb; 18(1):45-52. PubMed ID: 28993056
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
Cheng J; Wang Y; Mo M; Bao X; Zhang Y; Liu G; Zhang J; Geng D
Oncotarget; 2015 Oct; 6(30):29388-95. PubMed ID: 26336821
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment CT and
Rishi A; Zhang GG; Yuan Z; Sim AJ; Song EY; Moros EG; Tomaszewski MR; Latifi K; Pimiento JM; Fontaine JP; Mehta R; Harrison LB; Hoffe SE; Frakes JM
J Med Imaging Radiat Oncol; 2021 Feb; 65(1):102-111. PubMed ID: 33258556
[TBL] [Abstract][Full Text] [Related]
10. [Comparing prediction performances of
Vincent L; Jankowski C; Arnould L; Coudert B; Rouzier R; Reyal F; Humbert O; Coutant C
Gynecol Obstet Fertil Senol; 2020 Sep; 48(9):679-686. PubMed ID: 32205278
[TBL] [Abstract][Full Text] [Related]
11. Complete Metabolic Response on Interim
Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
[TBL] [Abstract][Full Text] [Related]
12. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
Antunovic L; De Sanctis R; Cozzi L; Kirienko M; Sagona A; Torrisi R; Tinterri C; Santoro A; Chiti A; Zelic R; Sollini M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1468-1477. PubMed ID: 30915523
[TBL] [Abstract][Full Text] [Related]
13. Utility of
Lee IH; Lee SJ; Lee J; Jung JH; Park HY; Jeong SY; Lee SW; Chae YS
BMC Cancer; 2020 Nov; 20(1):1106. PubMed ID: 33198673
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
15. The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI.
Choi EK; Yoo IR; Kim SH; Park SY; O JH; Kang BJ
Acta Radiol; 2018 Jan; 59(1):41-49. PubMed ID: 28427271
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
17. Predicting EGFR mutation subtypes in lung adenocarcinoma using
Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
[TBL] [Abstract][Full Text] [Related]
18.
Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
[No Abstract] [Full Text] [Related]
19. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
20. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
